BNR · Burning Rock Biotech Ltd · Debt

$15.83 -0.43 (-2.62%)

Market Cap

$199.75M

10.55M

Volume · Oct 5 49.04K Avg daily vol (3M) 30.01K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Noncurrent long-term debt and lease obligations	2025-12-31	CNY 1,700,000	20-F filed 2026-04-28
Noncurrent long-term debt and lease obligations	2025-12-31	USD 243,000	20-F filed 2026-04-28
Operating lease liabilities	2025-12-31	CNY 41,220,000	20-F filed 2026-04-28
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities CNY 16,762,000 Noncurrent operating lease liabilities CNY 24,458,000
Operating lease liabilities	2025-12-31	USD 5,894,000	20-F filed 2026-04-28
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities USD 2,397,000 Noncurrent operating lease liabilities USD 3,497,000

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1792267 CUSIP 12233L206 Visit website Investor relations